Nicola Mackie
Imperial College Healthcare NHS Trust(GB)Imperial College London(GB)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, Pneumocystis jirovecii pneumonia detection and treatment, HIV-related health complications and treatments
Most-Cited Works
- → A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine(2010)88 cited
- → Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV(2019)10 cited
- → Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction(2018)8 cited
- → Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance(2018)7 cited
- → Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process(2025)4 cited
- → The CONSENSUS-LAI Study: Establishing Shared Definitions of Virological Failure and Discontinuation for Long-Acting Injectable Cabotegravir and Rilpivirine Therapy(2025)
- → The evolution of antiretroviral-associated drug-resistance mutations in an individual receiving dolutegravir/lamivudine(2025)